Home›People›Neil Bhowmick
NB

Neil Bhowmick

Chief Scientific Officer at Kairos Pharma.

ExecutivePublic company
Updated Oct 29, 2026·Latest SEC filing Dec 30, 2025·Suggest an edit

About Neil Bhowmick

Neil Bhowmick is a chief scientific officer at Kairos Pharma.

Neil Bhowmick reports to the SEC as an officer of 1 public company.

Neil Bhowmick first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Neil Bhowmick in the role, so the role may have started earlier or lasted longer.

Kairos Pharma, LTD.
Chief Scientific Officer
2023 – 2025 · Public company (KAPA)

Key Colleagues at Startups

The people Neil Bhowmick works with at each company, as listed on that company's latest Form D.

Kairos Pharma, LTD. · Form D, Jan 28, 2025
HB
Hyun Bae
Independent Director
JY
John Yu
Chairman, Chief Executive Officer, and Director
HK
Hansoo Michael Keyoung
Independent Director
RM
Ramachandran Murali
Vice President of Research and Development
DS
Doug Samuelson
Chief Financial Officer
RS
Rahul Singhvi
Independent Director

Sources

  1. SECKairos Pharma, LTD. Form D, filed Jan 28, 2025
  2. SECForms 3, 4 and 5 filed by Neil Bhowmick (SEC filer 1872210)